Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine
- 1 December 2000
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 140 (6) , S136-S142
- https://doi.org/10.1067/mhj.2000.111608
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCirculation, 1999
- Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionThe American Journal of Cardiology, 1999
- Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care AssayJournal of Thrombosis and Thrombolysis, 1999
- PFA-100™ System: A New Method for Assessment of Platelet DysfunctionSeminars in Thrombosis and Hemostasis, 1998
- Rapid and Simple Platelet Function Assay to Assess Glycoprotein IIb/IIIa Receptor BlockadeCirculation, 1997